S. Rydén
Impact in
- Oncology top 5%
- Global Cancer Incidence and Screening
- Bone health and treatments
-
- Digital Radiography and Breast Imaging
- Gallbladder and Bile Duct Disorders
Papers in
- Oncology 8
- Bone health and treatments 5
- Global Cancer Incidence and Screening 1
-
- Liver physiology and pathology 2
- Co-authors
- Lars‐Gunnar Larsson (1 shared paper)A. Lindgren (1 shared paper)Jan Frisell (1 shared paper)Lars Erik Rutqvist (1 shared paper)Nils Bjurstam (1 shared paper)László K. Tabár (1 shared paper)Gunnar Fagerberg (1 shared paper)Stig Wall (1 shared paper)
In The Last Decade
S. Rydén
17 papers receiving 1.1k citations
S. Rydén's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 684
- Pulmonary and Respiratory Medicine 328
- Cancer Research 116
- Pathology and Forensic Medicine 84
- Hepatology 32
Countries citing papers authored by S. Rydén
This map shows the geographic impact of S. Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Rydén more than expected).
Fields of papers citing papers by S. Rydén
This network shows the impact of papers produced by S. Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Rydén. The network helps show where S. Rydén may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Rydén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Breast cancer screening with mammography: overview of Swedish randomised trials Hit paper breakdown → | 1993 | 788 |
| 2 | Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study. | 2000 | 97 |
| 3 | 1996 | 72 | |
| 4 | 1985 | 44 | |
| 5 | 1990 | 44 | |
| 6 | 1998 | 44 | |
| 7 | 1996 | 27 | |
| 8 | 1978 | 26 | |
| 9 | Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment. | 1991 | 19 |
| 10 | Low anterior resection using stapling instrument. | 1979 | 14 |
| 11 | 1986 | 10 | |
| 12 | 1995 | 8 | |
| 13 | 1985 | 5 | |
| 14 | 1985 | 3 | |
| 15 | Weekly dose adriamycin as first line chemotherapy in advanced breast cancer. | 1991 | 3 |
| 16 | 1995 | 2 | |
| 17 | 1995 | 1 |
About S. Rydén
S. Rydén is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Bone health and treatments (5 papers), Gallbladder and Bile Duct Disorders (4 papers), Breast Cancer Treatment Studies (3 papers), Liver physiology and pathology (2 papers), Estrogen and related hormone effects (2 papers), Cholesterol and Lipid Metabolism (1 paper), Global Cancer Incidence and Screening (1 paper) and Anesthesia and Pain Management (1 paper). The work is most often cited by research in Oncology (684 citations), Pulmonary and Respiratory Medicine (328 citations), Cancer Research (116 citations), Pathology and Forensic Medicine (84 citations) and Hepatology (32 citations). S. Rydén has collaborated with scholars based in Sweden and Germany. Frequent co-authors include Lars‐Gunnar Larsson, A. Lindgren, Jan Frisell, Lars Erik Rutqvist, Nils Bjurstam, László K. Tabár, Gunnar Fagerberg, Stig Wall, L. Nyström and Melker Lindqvist. Their work appears in journals such as Acta Oncologica, The Lancet, Scandinavian Journal of Gastroenterology, The American Journal of Surgery and Intensive and Critical Care Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.